Propria specializes in engineering heart tissues using iPSC-derived cardiomyocytes, providing innovative solutions for drug discovery, cardiotoxicity testing, and cardiac research. With advanced technology like the MyoPod analyzer, Propria enhances the accuracy of tissue contractility measurements, advancing the capabilities within healthcare and life sciences.
California, • United States
Berlin, • Germany • Biotechnology
Kanagawa, • Japan • Biotechnology
Minnesota, • United States
Zuid-Holland, • Netherlands • Healthcare Technology
High-throughput organ-on-a-chip, Human tissue disease models, Innovative drug discovery solutions, Scalable research platforms, Safety assessments for therapeutics
Hong Kong • Hong Kong • Internet and Technology
Wisconsin, • United States
California, • United States